Altavo, a Dresden, and Jena, Germany-based AI-based voice rehabilitation company, raised €5M in Series A funding.
The round was led by Occident with participation from Novalis Biotech, Beteiligungsmanagement Thüringen, TGFS Technologiegründerfonds Sachsen, High-Tech Gründerfonds (HTGF), Saxonia Systems Holding, and TUDAG TU Dresden AG.
The company intends to use the funds to accelerate growth, product development, the pivotal clinical trial, and internationalization.
Led by CEO Rudolf von Bünau, Altavo is advancing Artificial Voice, a medical device designed to help voiceless people, for example after laryngectomy or during mechanical ventilation, regain their own, natural sounding voice. The proprietary “silent speech” technology, which has been developed in collaboration with Technical University Dresden, is based on non-invasive radar sensing and the latest neural net architectures.
FinSMEs
20/02/2024